Event preview: Life Sciences IP Due Diligence summit

The continued success of a life sciences company hinges upon successful partnerships. There are many corporate transactions involving life sciences IP that necessitate conducting due diligence.

These include engaging team members in the face of a merger or acquisition, an initial public offering, venture capital financing, in-licensing, partnering, co-development, or distribution agreements. Structuring due diligence is entirely dependent upon the objectives.

The third Annual Summit on Life Sciences IP Due Diligence provides a forum for industry stakeholders to master how to cultivate, navigate, and apply the results of an effective and profitable due diligence analysis.

Attendees will benefit from in-depth sessions helping them to: